A NEW test for dementia, used
by the pharmacy industry in drug
trials to detect cognitive change in
participants, has been launched as
a tool to detect subtle changes that
could signify early stage dementia.
Melbourne-based Cogstate’s
computerised test, involving a deck
of playing cards, was launched
in partnership with Merck as
‘Cognigram’.
The results of a study using
the tool, published in BMC
Psychology, correlated well with
measures of disease classification
and “are useful in identifying
memory impairment related to
mild cognitive impairment and
Alzheimer’s disease.”
For more CLICK HERE.The above article was sent to subscribers in Pharmacy Daily's issue from 17 Jan 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 17 Jan 14
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.